Bortezomib-based consolidation or maintenance therapy for multiple myeloma: a meta-analysis

Bortezomib-based regimens are widely used as induction therapy for multiple myeloma (MM). Unlike lenalidomide, the role of bortezomib in consolidation and maintenance therapy for MM is less clear. We performed a meta-analysis to evaluate the impact of bortezomib-based consolidation and maintenance t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shijia, Kulkarni, Amit A., Xu, Beibei, Chu, Haitao, Kourelis, Taxiarchis, Go, Ronald S., Wang, Michael L., Bachanova, Veronika, Wang, Yucai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060191/
https://www.ncbi.nlm.nih.gov/pubmed/32144237
http://dx.doi.org/10.1038/s41408-020-0298-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060191/
https://www.ncbi.nlm.nih.gov/pubmed/32144237
http://dx.doi.org/10.1038/s41408-020-0298-1

Ejemplares similares